APO Research
Talk to an analyst

APO RESEARCH · REPORT

Competent Cells

Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.

Selected research

Market Outlook & Growth Opportunities

Global Competent Cells Market Outlook and Growth Opportunities 2026

21 December 2025217 pages

Choose your research edition.

Industry ResearchCompetent Cells Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Competent Cells Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Competent Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Competent Cells Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Competent Cells Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.

Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.

North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent.

Read the full market overview

In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.

This report provides an overview of the global Competent Cells market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Competent Cells and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Competent Cells revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Competent Cells market.

Competent Cells Segment by Company

Merck KGaA

Thermo Fisher Scientific

Agilent Technologies

Takara Bio

Promega Corporation

Beijing TransGen Biotech

GeneScript Corporation

Yeastern Biotech

New England Biolabs

QIAGEN N.V.

OriGene Technologies

Lucigen

Zymo Research

Bio-Rad Laboratories

Bioline

Delphi Genetics

IBA GmBH

Cell Applications

BioDynamics Laboratory

Scarab Genomics

GCC Biotech

SMOBIO Technology

Edge BioSystems

Competent Cells Segment by Type

Chemically Competent Cells

Electrocompetent Cells

Competent Cells Segment by Application

Subcloning & Routine Cloning

Phage Display Library Construction

Toxic/Unstable DNA Cloning

High-Throughput Cloning

Protein Expression

Mutagenesis

Single-Stranded DNA Production

Bacmid Creation

Cre-Lox Recombination (PIR1/PIR2)

Competent Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Competent Cells status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Competent Cells key companies, revenue, market share, and recent developments.

3. To split the Competent Cells breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Competent Cells market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Competent Cells significant trends, drivers, influence factors in global and regions.

6. To analyze Competent Cells competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Competent Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Competent Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Competent Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Competent Cells industry.

Chapter 3: Detailed analysis of Competent Cells company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Competent Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Competent Cells in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Competent Cells Industry Trends Table 2. Competent Cells Industry Drivers Table 3. Competent Cells Industry Opportunities and Challenges Table 4. Competent Cells Industry Restraints Table 5. Global Competent Cells Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Competent Cells Revenue Share by Company (2021-2026) Table 7. Global Competent Cells Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Competent Cells Key Company Manufacturing Base & Headquarters Table 9. Global Competent Cells Company, Product Type & Application Table 10. Global Competent Cells Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Competent Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Chemically Competent Cells Table 15. Significant Companies of Electrocompetent Cells Table 16. Global Competent Cells Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Competent Cells Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Competent Cells Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Competent Cells Sales Value Share by Type (2021-2026) Table 20. Global Competent Cells Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Subcloning & Routine Cloning Table 22. Significant Companies of Phage Display Library Construction Table 23. Significant Companies of Toxic/Unstable DNA Cloning Table 24. Significant Companies of High-Throughput Cloning Table 25. Significant Companies of Protein Expression Table 26. Significant Companies of Mutagenesis Table 27. Significant Companies of Single-Stranded DNA Production Table 28. Significant Companies of Bacmid Creation Table 29. Significant Companies of Cre-Lox Recombination (PIR1/PIR2) Table 30. Global Competent Cells Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Competent Cells Sales Value by Application (2021-2026) & (US$ Million) Table 32. Global Competent Cells Sales Value by Application (2027-2032) & (US$ Million) Table 33. Global Competent Cells Sales Value Share by Application (2021-2026) Table 34. Global Competent Cells Sales Value Share by Application (2027-2032) Table 35. Global Competent Cells Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Competent Cells Sales Value by Region (2021-2026) & (US$ Million) Table 37. Global Competent Cells Sales Value Share by Region (2021-2026) Table 38. Global Competent Cells Sales Value by Region (2027-2032) & (US$ Million) Table 39. Global Competent Cells Sales Value Share by Region (2027-2032) Table 40. Global Competent Cells Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Competent Cells Sales Value by Country (2021-2026) & (US$ Million) Table 42. Global Competent Cells Sales Value Market Share by Country (2021-2026) Table 43. Global Competent Cells Sales Value by Country (2027-2032) & (US$ Million) Table 44. Global Competent Cells Sales Value Market Share by Country (2027-2032) Table 45. Merck KGaA Company Information Table 46. Merck KGaA Business Overview Table 47. Merck KGaA Competent Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Merck KGaA Competent Cells Product Portfolio Table 49. Merck KGaA Recent Development Table 50. Thermo Fisher Scientific Company Information Table 51. Thermo Fisher Scientific Business Overview Table 52. Thermo Fisher Scientific Competent Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Thermo Fisher Scientific Competent Cells Product Portfolio Table 54. Thermo Fisher Scientific Recent Development Table 55. Agilent Technologies Company Information Table 56. Agilent Technologies Business Overview Table 57. Agilent Technologies Competent Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Agilent Technologies Competent Cells Product Portfolio Table 59. Agilent Technologies Recent Development Table 60. Takara Bio Company Information Table 61. Takara Bio Business Overview Table 62. Takara Bio Competent Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Takara Bio Competent Cells Product Portfolio Table 64. Takara Bio Recent Development Table 65. Promega Corporation Company Information Table 66. Promega Corporation Business Overview Table 67. Promega Corporation Competent Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Promega Corporation Competent Cells Product Portfolio Table 69. Promega Corporation Recent Development Table 70. Beijing TransGen Biotech Company Information Table 71. Beijing TransGen Biotech Business Overview Table 72. Beijing TransGen Biotech Competent Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Beijing TransGen Biotech Competent Cells Product Portfolio Table 74. Beijing TransGen Biotech Recent Development Table 75. GeneScript Corporation Company Information Table 76. GeneScript Corporation Business Overview Table 77. GeneScript Corporation Competent Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. GeneScript Corporation Competent Cells Product Portfolio Table 79. GeneScript Corporation Recent Development Table 80. Yeastern Biotech Company Information Table 81. Yeastern Biotech Business Overview Table 82. Yeastern Biotech Competent Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Yeastern Biotech Competent Cells Product Portfolio Table 84. Yeastern Biotech Recent Development Table 85. New England Biolabs Company Information Table 86. New England Biolabs Business Overview Table 87. New England Biolabs Competent Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. New England Biolabs Competent Cells Product Portfolio Table 89. New England Biolabs Recent Development Table 90. QIAGEN N.V. Company Information Table 91. QIAGEN N.V. Business Overview Table 92. QIAGEN N.V. Competent Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. QIAGEN N.V. Competent Cells Product Portfolio Table 94. QIAGEN N.V. Recent Development Table 95. OriGene Technologies Company Information Table 96. OriGene Technologies Business Overview Table 97. OriGene Technologies Competent Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. OriGene Technologies Competent Cells Product Portfolio Table 99. OriGene Technologies Recent Development Table 100. Lucigen Company Information Table 101. Lucigen Business Overview Table 102. Lucigen Competent Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Lucigen Competent Cells Product Portfolio Table 104. Lucigen Recent Development Table 105. Zymo Research Company Information Table 106. Zymo Research Business Overview Table 107. Zymo Research Competent Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. Zymo Research Competent Cells Product Portfolio Table 109. Zymo Research Recent Development Table 110. Bio-Rad Laboratories Company Information Table 111. Bio-Rad Laboratories Business Overview Table 112. Bio-Rad Laboratories Competent Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. Bio-Rad Laboratories Competent Cells Product Portfolio Table 114. Bio-Rad Laboratories Recent Development Table 115. Bioline Company Information Table 116. Bioline Business Overview Table 117. Bioline Competent Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 118. Bioline Competent Cells Product Portfolio Table 119. Bioline Recent Development Table 120. Delphi Genetics Company Information Table 121. Delphi Genetics Business Overview Table 122. Delphi Genetics Competent Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 123. Delphi Genetics Competent Cells Product Portfolio Table 124. Delphi Genetics Recent Development Table 125. IBA GmBH Company Information Table 126. IBA GmBH Business Overview Table 127. IBA GmBH Competent Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 128. IBA GmBH Competent Cells Product Portfolio Table 129. IBA GmBH Recent Development Table 130. Cell Applications Company Information Table 131. Cell Applications Business Overview Table 132. Cell Applications Competent Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 133. Cell Applications Competent Cells Product Portfolio Table 134. Cell Applications Recent Development Table 135. BioDynamics Laboratory Company Information Table 136. BioDynamics Laboratory Business Overview Table 137. BioDynamics Laboratory Competent Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 138. BioDynamics Laboratory Competent Cells Product Portfolio Table 139. BioDynamics Laboratory Recent Development Table 140. Scarab Genomics Company Information Table 141. Scarab Genomics Business Overview Table 142. Scarab Genomics Competent Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 143. Scarab Genomics Competent Cells Product Portfolio Table 144. Scarab Genomics Recent Development Table 145. GCC Biotech Company Information Table 146. GCC Biotech Business Overview Table 147. GCC Biotech Competent Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 148. GCC Biotech Competent Cells Product Portfolio Table 149. GCC Biotech Recent Development Table 150. SMOBIO Technology Company Information Table 151. SMOBIO Technology Business Overview Table 152. SMOBIO Technology Competent Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 153. SMOBIO Technology Competent Cells Product Portfolio Table 154. SMOBIO Technology Recent Development Table 155. Edge BioSystems Company Information Table 156. Edge BioSystems Business Overview Table 157. Edge BioSystems Competent Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 158. Edge BioSystems Competent Cells Product Portfolio Table 159. Edge BioSystems Recent Development Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Competent Cells Product Image Figure 2. Global Competent Cells Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Competent Cells Market Size (2021-2032) & (US$ Million) Figure 4. Global Competent Cells Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Chemically Competent Cells Image Figure 8. Electrocompetent Cells Image Figure 9. Global Competent Cells Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Competent Cells Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Competent Cells Sales Value Share by Type (2021-2032) Figure 12. Subcloning & Routine Cloning Image Figure 13. Phage Display Library Construction Image Figure 14. Toxic/Unstable DNA Cloning Image Figure 15. High-Throughput Cloning Image Figure 16. Protein Expression Image Figure 17. Mutagenesis Image Figure 18. Single-Stranded DNA Production Image Figure 19. Bacmid Creation Image Figure 20. Cre-Lox Recombination (PIR1/PIR2) Image Figure 21. Global Competent Cells Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Competent Cells Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global Competent Cells Sales Value Share by Application (2021-2032) Figure 24. Global Competent Cells Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 25. Global Competent Cells Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 26. North America Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 27. North America Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Europe Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 29. Europe Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Asia-Pacific Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 31. Asia-Pacific Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 32. South America Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 33. South America Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Middle East & Africa Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 36. USA Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. USA Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. USA Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Canada Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Canada Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Canada Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Mexico Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Mexico Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Mexico Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Germany Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Germany Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Germany Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. France Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. France Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. France Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. U.K. Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. U.K. Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. U.K. Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Italy Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Italy Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Italy Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Spain Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Spain Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Spain Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Russia Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Russia Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Russia Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Netherlands Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Netherlands Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Netherlands Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Nordic Countries Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Nordic Countries Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Nordic Countries Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. China Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. China Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. China Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Japan Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Japan Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Japan Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. South Korea Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. South Korea Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. South Korea Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. India Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. India Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. India Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Australia Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Australia Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Australia Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Southeast Asia Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Southeast Asia Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Southeast Asia Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Brazil Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Brazil Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Brazil Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Argentina Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Argentina Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Argentina Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Chile Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Chile Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Chile Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Colombia Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Colombia Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Colombia Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Peru Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Peru Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Peru Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Saudi Arabia Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Saudi Arabia Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Israel Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Israel Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Israel Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. UAE Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. UAE Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. UAE Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Turkey Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Turkey Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Turkey Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Iran Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Iran Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Iran Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Egypt Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Egypt Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Egypt Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Years Considered Figure 121. Research Process Figure 122. Key Executives Interviewed

Scope & coverage.

Types
  • Chemically Competent Cells
  • Electrocompetent Cells
Applications
  • Subcloning & Routine Cloning
  • Phage Display Library Construction
  • Toxic/Unstable DNA Cloning
  • High-Throughput Cloning
  • Protein Expression
  • Mutagenesis
  • Single-Stranded DNA Production
  • Bacmid Creation
  • Cre-Lox Recombination (PIR1/PIR2)
Companies covered
  • Merck KGaA
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Takara Bio
  • Promega Corporation
  • Beijing TransGen Biotech
  • GeneScript Corporation
  • Yeastern Biotech
  • New England Biolabs
  • QIAGEN N.V.
  • OriGene Technologies
  • Lucigen
  • Zymo Research
  • Bio-Rad Laboratories
  • Bioline
  • Delphi Genetics
  • IBA GmBH
  • Cell Applications
  • BioDynamics Laboratory
  • Scarab Genomics
  • GCC Biotech
  • SMOBIO Technology
  • Edge BioSystems

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Competent Cells Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Competent Cells Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Competent Cells Market Dynamics
  1. 2.1 Competent Cells Industry Trends
  2. 2.2 Competent Cells Industry Drivers
  3. 2.3 Competent Cells Industry Opportunities and Challenges
  4. 2.4 Competent Cells Industry Restraints
3 Competent Cells Market by Company
  1. 3.1 Global Competent Cells Company Revenue Ranking in 2025
  2. 3.2 Global Competent Cells Revenue by Company (2021-2026)
  3. 3.3 Global Competent Cells Company Ranking (2024-2026)
  4. 3.4 Global Competent Cells Company Manufacturing Base and Headquarters
  5. 3.5 Global Competent Cells Company Product Type and Application
  6. 3.6 Global Competent Cells Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Competent Cells Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Competent Cells Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Competent Cells Market by Type
  1. 4.1 Competent Cells Type Introduction
  2. 4.1.1 Chemically Competent Cells
  3. 4.1.2 Electrocompetent Cells
  4. 4.2 Global Competent Cells Sales Value by Type
  5. 4.2.1 Global Competent Cells Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Competent Cells Sales Value by Type (2021-2032)
  7. 4.2.3 Global Competent Cells Sales Value Share by Type (2021-2032)
5 Competent Cells Market by Application
  1. 5.1 Competent Cells Application Introduction
  2. 5.1.1 Subcloning & Routine Cloning
  3. 5.1.2 Phage Display Library Construction
  4. 5.1.3 Toxic/Unstable DNA Cloning
  5. 5.1.4 High-Throughput Cloning
  6. 5.1.5 Protein Expression
  7. 5.1.6 Mutagenesis
  8. 5.1.7 Single-Stranded DNA Production
  9. 5.1.8 Bacmid Creation
  10. 5.1.9 Cre-Lox Recombination (PIR1/PIR2)
  11. 5.2 Global Competent Cells Sales Value by Application
  12. 5.2.1 Global Competent Cells Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.2.2 Global Competent Cells Sales Value by Application (2021-2032)
  14. 5.2.3 Global Competent Cells Sales Value Share by Application (2021-2032)
6 Competent Cells Regional Value Analysis
  1. 6.1 Global Competent Cells Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Competent Cells Sales Value by Region (2021-2032)
  3. 6.2.1 Global Competent Cells Sales Value by Region: 2021-2026
  4. 6.2.2 Global Competent Cells Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Competent Cells Sales Value (2021-2032)
  7. 6.3.2 North America Competent Cells Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Competent Cells Sales Value (2021-2032)
  10. 6.4.2 Europe Competent Cells Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Competent Cells Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Competent Cells Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Competent Cells Sales Value (2021-2032)
  16. 6.6.2 South America Competent Cells Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Competent Cells Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Competent Cells Sales Value Share by Country, 2025 VS 2032
7 Competent Cells Country-level Value Analysis
  1. 7.1 Global Competent Cells Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Competent Cells Sales Value by Country (2021-2032)
  3. 7.2.1 Global Competent Cells Sales Value by Country (2021-2026)
  4. 7.2.2 Global Competent Cells Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Competent Cells Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Competent Cells Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Competent Cells Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Competent Cells Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Competent Cells Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Competent Cells Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Competent Cells Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Competent Cells Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Competent Cells Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Competent Cells Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Competent Cells Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Competent Cells Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Competent Cells Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Competent Cells Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Competent Cells Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Competent Cells Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Competent Cells Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Competent Cells Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Competent Cells Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Competent Cells Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Competent Cells Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Competent Cells Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Competent Cells Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Competent Cells Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Competent Cells Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Competent Cells Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Competent Cells Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Competent Cells Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Competent Cells Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Competent Cells Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Competent Cells Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Competent Cells Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Competent Cells Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Competent Cells Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Competent Cells Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Competent Cells Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Competent Cells Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Competent Cells Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Competent Cells Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Competent Cells Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Competent Cells Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Competent Cells Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Competent Cells Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Competent Cells Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Competent Cells Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Competent Cells Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Competent Cells Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Competent Cells Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Competent Cells Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Competent Cells Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Competent Cells Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Competent Cells Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Competent Cells Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Competent Cells Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Competent Cells Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Competent Cells Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Competent Cells Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Competent Cells Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Competent Cells Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Competent Cells Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Competent Cells Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Competent Cells Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Competent Cells Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Competent Cells Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Competent Cells Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Competent Cells Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Competent Cells Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Competent Cells Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Competent Cells Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Competent Cells Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Competent Cells Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Competent Cells Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Competent Cells Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Competent Cells Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Competent Cells Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Competent Cells Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Competent Cells Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Competent Cells Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Competent Cells Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Competent Cells Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Competent Cells Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Competent Cells Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Competent Cells Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Competent Cells Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck KGaA
  2. 8.1.1 Merck KGaA Company Information
  3. 8.1.2 Merck KGaA Business Overview
  4. 8.1.3 Merck KGaA Competent Cells Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck KGaA Competent Cells Product Portfolio
  6. 8.1.5 Merck KGaA Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Competent Cells Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Competent Cells Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 Agilent Technologies
  14. 8.3.1 Agilent Technologies Company Information
  15. 8.3.2 Agilent Technologies Business Overview
  16. 8.3.3 Agilent Technologies Competent Cells Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Agilent Technologies Competent Cells Product Portfolio
  18. 8.3.5 Agilent Technologies Recent Developments
  19. 8.4 Takara Bio
  20. 8.4.1 Takara Bio Company Information
  21. 8.4.2 Takara Bio Business Overview
  22. 8.4.3 Takara Bio Competent Cells Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Takara Bio Competent Cells Product Portfolio
  24. 8.4.5 Takara Bio Recent Developments
  25. 8.5 Promega Corporation
  26. 8.5.1 Promega Corporation Company Information
  27. 8.5.2 Promega Corporation Business Overview
  28. 8.5.3 Promega Corporation Competent Cells Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Promega Corporation Competent Cells Product Portfolio
  30. 8.5.5 Promega Corporation Recent Developments
  31. 8.6 Beijing TransGen Biotech
  32. 8.6.1 Beijing TransGen Biotech Company Information
  33. 8.6.2 Beijing TransGen Biotech Business Overview
  34. 8.6.3 Beijing TransGen Biotech Competent Cells Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Beijing TransGen Biotech Competent Cells Product Portfolio
  36. 8.6.5 Beijing TransGen Biotech Recent Developments
  37. 8.7 GeneScript Corporation
  38. 8.7.1 GeneScript Corporation Company Information
  39. 8.7.2 GeneScript Corporation Business Overview
  40. 8.7.3 GeneScript Corporation Competent Cells Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GeneScript Corporation Competent Cells Product Portfolio
  42. 8.7.5 GeneScript Corporation Recent Developments
  43. 8.8 Yeastern Biotech
  44. 8.8.1 Yeastern Biotech Company Information
  45. 8.8.2 Yeastern Biotech Business Overview
  46. 8.8.3 Yeastern Biotech Competent Cells Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Yeastern Biotech Competent Cells Product Portfolio
  48. 8.8.5 Yeastern Biotech Recent Developments
  49. 8.9 New England Biolabs
  50. 8.9.1 New England Biolabs Company Information
  51. 8.9.2 New England Biolabs Business Overview
  52. 8.9.3 New England Biolabs Competent Cells Revenue and Gross Margin (2021-2026)
  53. 8.9.4 New England Biolabs Competent Cells Product Portfolio
  54. 8.9.5 New England Biolabs Recent Developments
  55. 8.10 QIAGEN N.V.
  56. 8.10.1 QIAGEN N.V. Company Information
  57. 8.10.2 QIAGEN N.V. Business Overview
  58. 8.10.3 QIAGEN N.V. Competent Cells Revenue and Gross Margin (2021-2026)
  59. 8.10.4 QIAGEN N.V. Competent Cells Product Portfolio
  60. 8.10.5 QIAGEN N.V. Recent Developments
  61. 8.11 OriGene Technologies
  62. 8.11.1 OriGene Technologies Company Information
  63. 8.11.2 OriGene Technologies Business Overview
  64. 8.11.3 OriGene Technologies Competent Cells Revenue and Gross Margin (2021-2026)
  65. 8.11.4 OriGene Technologies Competent Cells Product Portfolio
  66. 8.11.5 OriGene Technologies Recent Developments
  67. 8.12 Lucigen
  68. 8.12.1 Lucigen Company Information
  69. 8.12.2 Lucigen Business Overview
  70. 8.12.3 Lucigen Competent Cells Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Lucigen Competent Cells Product Portfolio
  72. 8.12.5 Lucigen Recent Developments
  73. 8.13 Zymo Research
  74. 8.13.1 Zymo Research Company Information
  75. 8.13.2 Zymo Research Business Overview
  76. 8.13.3 Zymo Research Competent Cells Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Zymo Research Competent Cells Product Portfolio
  78. 8.13.5 Zymo Research Recent Developments
  79. 8.14 Bio-Rad Laboratories
  80. 8.14.1 Bio-Rad Laboratories Company Information
  81. 8.14.2 Bio-Rad Laboratories Business Overview
  82. 8.14.3 Bio-Rad Laboratories Competent Cells Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bio-Rad Laboratories Competent Cells Product Portfolio
  84. 8.14.5 Bio-Rad Laboratories Recent Developments
  85. 8.15 Bioline
  86. 8.15.1 Bioline Company Information
  87. 8.15.2 Bioline Business Overview
  88. 8.15.3 Bioline Competent Cells Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Bioline Competent Cells Product Portfolio
  90. 8.15.5 Bioline Recent Developments
  91. 8.16 Delphi Genetics
  92. 8.16.1 Delphi Genetics Company Information
  93. 8.16.2 Delphi Genetics Business Overview
  94. 8.16.3 Delphi Genetics Competent Cells Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Delphi Genetics Competent Cells Product Portfolio
  96. 8.16.5 Delphi Genetics Recent Developments
  97. 8.17 IBA GmBH
  98. 8.17.1 IBA GmBH Company Information
  99. 8.17.2 IBA GmBH Business Overview
  100. 8.17.3 IBA GmBH Competent Cells Revenue and Gross Margin (2021-2026)
  101. 8.17.4 IBA GmBH Competent Cells Product Portfolio
  102. 8.17.5 IBA GmBH Recent Developments
  103. 8.18 Cell Applications
  104. 8.18.1 Cell Applications Company Information
  105. 8.18.2 Cell Applications Business Overview
  106. 8.18.3 Cell Applications Competent Cells Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Cell Applications Competent Cells Product Portfolio
  108. 8.18.5 Cell Applications Recent Developments
  109. 8.19 BioDynamics Laboratory
  110. 8.19.1 BioDynamics Laboratory Company Information
  111. 8.19.2 BioDynamics Laboratory Business Overview
  112. 8.19.3 BioDynamics Laboratory Competent Cells Revenue and Gross Margin (2021-2026)
  113. 8.19.4 BioDynamics Laboratory Competent Cells Product Portfolio
  114. 8.19.5 BioDynamics Laboratory Recent Developments
  115. 8.20 Scarab Genomics
  116. 8.20.1 Scarab Genomics Company Information
  117. 8.20.2 Scarab Genomics Business Overview
  118. 8.20.3 Scarab Genomics Competent Cells Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Scarab Genomics Competent Cells Product Portfolio
  120. 8.20.5 Scarab Genomics Recent Developments
  121. 8.21 GCC Biotech
  122. 8.21.1 GCC Biotech Company Information
  123. 8.21.2 GCC Biotech Business Overview
  124. 8.21.3 GCC Biotech Competent Cells Revenue and Gross Margin (2021-2026)
  125. 8.21.4 GCC Biotech Competent Cells Product Portfolio
  126. 8.21.5 GCC Biotech Recent Developments
  127. 8.22 SMOBIO Technology
  128. 8.22.1 SMOBIO Technology Company Information
  129. 8.22.2 SMOBIO Technology Business Overview
  130. 8.22.3 SMOBIO Technology Competent Cells Revenue and Gross Margin (2021-2026)
  131. 8.22.4 SMOBIO Technology Competent Cells Product Portfolio
  132. 8.22.5 SMOBIO Technology Recent Developments
  133. 8.23 Edge BioSystems
  134. 8.23.1 Edge BioSystems Company Information
  135. 8.23.2 Edge BioSystems Business Overview
  136. 8.23.3 Edge BioSystems Competent Cells Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Edge BioSystems Competent Cells Product Portfolio
  138. 8.23.5 Edge BioSystems Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst